Convelo Therapeutics

    OverviewSuggest Edit

    Convelo Therapeutics is a company that provides medicines focusing on the regenerative capacity of the central nervous system. It develops drugs to regenerate the protective myelin coating around nerve cells and restore function in patients with neurological disorders. The company focuses on multiple sclerosis, pediatric leukodystrophies, traumatic injury, and age-related pathologies such as Alzheimer’s.
    TypePrivate
    Founded2016
    Websiteconvelotx.com

    Latest Updates

    Employees (est.) (Mar 2020)14

    Convelo Therapeutics Financials and Metrics

    Summary Metrics

    Founding Date

    2016
    Show all financial metrics

    Convelo Therapeutics Online and Social Media Presence

    Embed Graph

    Convelo Therapeutics Frequently Asked Questions

    • When was Convelo Therapeutics founded?

      Convelo Therapeutics was founded in 2016.

    • How many employees does Convelo Therapeutics have?

      Convelo Therapeutics has 14 employees.

    • Who are Convelo Therapeutics competitors?

      Competitors of Convelo Therapeutics include Aimmune Therapeutics, Cidara Therapeutics and Genprex.